跳至主要内容
临床试验/JPRN-jRCT1031220298
JPRN-jRCT1031220298招募中4 期

A double-blinded, randomised, clinical trial about the effect of rebamipide ophthalmic suspension in dry eye with the Sjogren syndrome patients. - Mucosta trial

Shimizu Daisuke0 个研究点目标入组 40 人开始时间: 2022年8月27日最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 18age old 至 ot applicable(—)
性别
All

入选标准

  • Patients who meet all of the following criteria will be considered
  • (1) Written consent has been obtained from the patient or a surrogate
  • (2) Men and women who are at least 18 years of age at the time of consent acquisition.
  • (3) Patient must have a diagnosis of Sjogren's syndrome based on the revised diagnostic criteria of the Ministry of Health in 1999.
  • (4) Patient has a diagnosis of dry eye based on the revised dry eye practice guideline criteria by the 2019 Dry Eye Study Group Practice Guideline Development Committee.

排除标准

  • Patients who meet all of the following criteria will be considered.
  • (1) Patients with active inflammatory ocular or eyelid disease.
  • (2) Patients with eyelid closure defects.
  • (3) Patients with a history of graft-versus-host disease.
  • (4) Other persons deemed by the principal investigator or subinvestigator to be inappropriate for the safe conduct of this study.

研究者

发起方
Shimizu Daisuke

相似试验